A61K 39/0233
Rickettsiales
Official title: {Rickettsiales, e.g. Anaplasma}
A61K39/0233 (Rickettsiales) appears on 99 US grants and 105 published applications in this corpus.
Search patents in A61K- Granted patents
- 99
- Published applications
- 105
- Assignees
- 62
- Inventors
- 145
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 1 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 5 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 3 |
| 2003 | 0 | 0 |
| 2004 | 1 | 1 |
| 2005 | 2 | 5 |
| 2006 | 0 | 4 |
| 2007 | 2 | 1 |
| 2008 | 1 | 1 |
| 2009 | 2 | 6 |
| 2010 | 5 | 6 |
| 2011 | 4 | 8 |
| 2012 | 2 | 3 |
| 2013 | 2 | 3 |
| 2014 | 7 | 5 |
| 2015 | 4 | 5 |
| 2016 | 4 | 6 |
| 2017 | 9 | 9 |
| 2018 | 6 | 8 |
| 2019 | 8 | 7 |
| 2020 | 5 | 9 |
| 2021 | 5 | 5 |
| 2022 | 2 | 3 |
| 2023 | 4 | 1 |
| 2024 | 0 | 2 |
| 2025 | 5 | 2 |
| 2026 | 3 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Ehrlichia vaccines and immunogenic compositions12 May 2026US 12,624,093 B2Research Development Foundation
- Serum free intracellular pathogen vaccine3 Mar 2026US 12,564,626 B2Intervet Inc.
- Chimeric immunogenic polypeptides17 Feb 2026US 12,552,843 B2Research Development Foundation
- Vaccines against tick-borne diseases19 Aug 2025US 12,390,516 B2Kansas State University Research Foundation
- Ehrlichia ruminantium immunogenic compositions and methods of using thereof5 Aug 2025US 12,377,139 B2Kansas State University Research Foundation
- Ehrlichia vaccines and immunogenic compositions20 Aug 2026US 2026/0242451 A1Research Development Foundation
- Serum free intracellular pathogen vaccine11 Jun 2026US 2026/0158132 A1Intervet Inc.
- Anaplasma vaccines and methods of use thereof22 May 2025US 2025/0161426 A1Kansas State University Research Foundation
- Immunoreactive peptides22 May 2025US 2025/0161427 A1Research Development Foundation
- Immunoreactive peptides26 Dec 2024US 2024/0424075 A1Research Development Foundation
Most cited
By later US patents
- Method of growing rickettsiae in Ixodes scapularis tick cell culture and preparing antigens and vaccines of rickettsiae40US 5,869,335 ARegents of the University of Minnesota · 1999
- Encapsulated vaccines for the oral vaccination and boostering of fish and other animals40US 7,998,502 B2Advanced Bionutrition Corporation · 2011
- Method of diagnosing human granulocytic Ehrlichiosis38US 5,928,879 ARegents of the University of Minnesota · 1999
- Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods37US 6,284,238 B1Aquila Biopharmaceuticals, Inc. · 2001
- Cell lines infected with granulocytic ehrlichia, vaccines, diagnostics and methods28US 5,976,860 AAquila Biopharmaceuticals, Inc. · 1999